MCM
MBIO icon

MAI Capital Management’s Mustang Bio MBIO Stock Holding History

MAI Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$3 – 3620
2026
Q1 		$3 Hold
3
– – ﹤0.01% 5002
2025
Q4 		$3 Buy
+3
New +$4 ﹤0.01% 4342
2023
Q2 		– Sell
-27
Closed -$7.33K – 1104
2023
Q1 		$7.33K Hold
27
– – ﹤0.01% 1029
2022
Q4 		$7.9K Buy
+27
New +$9.22K ﹤0.01% 998

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CG
CFO4Life Group Coppell, Texas $743M AUM 25.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

MAI Capital Management's MBIO Position: Q2 2026 in Review

MAI Capital Management sold out of Mustang Bio (MBIO) in Q2 2026, closing a stake of 3 shares — an estimated $3 sold.

MAI Capital Management first reported a position in MBIO in Q4 2022 and held it in 4 quarters. The position peaked at $7.9K in Q4 2022. 23 funds tracked by Wall St. Rank hold MBIO as of Q2 2026.

  • MAI Capital Management reported no remaining Mustang Bio position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 3 Mustang Bio shares in Q2 2026, an estimated $3.
  • MAI Capital Management first reported a position in Mustang Bio in Q4 2022 and held it in 4 quarters.
  • MAI Capital Management's Mustang Bio position peaked at $7.9K in Q4 2022.
  • 23 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.